中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [77]
武汉病毒研究所 [14]
上海生物化学与细胞... [11]
生态环境研究中心 [9]
中国科学院大学 [5]
地理科学与资源研究所 [4]
更多
采集方式
OAI收割 [145]
iSwitch采集 [19]
内容类型
期刊论文 [161]
SCI/SSCI论文 [2]
学位论文 [1]
发表日期
2024 [2]
2023 [16]
2022 [29]
2021 [26]
2020 [16]
2019 [1]
更多
学科主题
Biochemist... [6]
Cell Biolo... [3]
Biochemist... [2]
Chemistry [2]
Science & ... [2]
Virology [2]
更多
筛选
浏览/检索结果:
共164条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
发表日期升序
发表日期降序
The human microbiota is a beneficial reservoir for SARS-CoV-2 mutations
期刊论文
OAI收割
MBIO, 2024, 页码: 15
作者:
Cao, Birong
;
Wang, Xiaoxi
;
Yin, Wanchao
;
Gao, Zhaobing
;
Xia, Bingqing
  |  
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2024/05/07
human microbiota
SARS-CoV-2 advantageous mutations
evolution
Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19
期刊论文
OAI收割
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 卷号: 390, 期号: 3, 页码: 230-241
作者:
Cao, Bin
;
Wang, Yeming
;
Lu, Hongzhou
;
Huang, Chaolin
;
Yang, Yumei
  |  
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2024/05/07
A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects
期刊论文
OAI收割
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 卷号: 191, 页码: 9
作者:
Yang, Xin-Mei
;
Yang, Yang
;
Yao, Bu-Fan
;
Ye, Pan-Pan
;
Xu, Yan
  |  
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2023/12/11
COVID-19
Simnotrelvir
Safety
Pharmacokinetics
Healthy subjects
Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir
期刊论文
OAI收割
NATURE COMMUNICATIONS, 2023, 卷号: 14, 期号: 1, 页码: 15
作者:
Jiang, Xiangrui
;
Su, Haixia
;
Shang, Weijuan
;
Zhou, Feng
;
Zhang, Yan
  |  
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2024/03/25
COVID-19-related Olfactory Dysfunction: Prevalence, Mechanism and Recovery
期刊论文
OAI收割
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2023, 卷号: 50, 期号: 6, 页码: 1245-1260
作者:
Xing, Chen
;
Ma, Jing-Chao
;
Yun, Han-Qi
;
Liu, Qing-Jing
;
Chang, Xiao-Yue
  |  
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2023/10/09
COVID-19
olfactory dysfunction
SARS-CoV-2
SARS-CoV-2 variants
long COVID
olfactory training
Sensitivity-enhanced nanoplasmonic biosensor using direct immobilization of two engineered nanobodies for SARS-CoV-2 spike receptor-binding domain detection
期刊论文
OAI收割
SENSORS AND ACTUATORS B-CHEMICAL, 2023, 卷号: 383, 页码: 133575
作者:
Ma, Zhengtai
;
Sun, Zengchao
;
Lv, Xiaoqing
;
Chen, Hongda
;
Geng, Yong
  |  
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2024/03/27
Nanoplasmonics
Biosensor
COVID-19
Nanobody
Immobilization
High -throughput
Structure-Based Design of Potent Peptidomimetic Inhibitors Covalently Targeting SARS-CoV-2 Papain-like Protease
期刊论文
OAI收割
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 卷号: 24, 期号: 10, 页码: 15
作者:
Wang, Qian
;
Chen, Guofeng
;
He, Jian
;
Li, Jiameng
;
Xiong, Muya
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2023/10/17
SARS-CoV-2
papain-like protease
covalent inhibitor
co-crystal structure
in vitro assay
Discovery, synthesis and mechanism study of 2,3,5-substituted [1,2,4]-thiadiazoles as covalent inhibitors targeting 3C-Like protease of SARS-CoV-2
期刊论文
OAI收割
European journal of medicinal chemistry, 2023, 卷号: 249, 页码: 115129
作者:
Ren, Pengxuan
;
Yu, Changyue
;
Zhang, Ruxue
;
Nie, Tianqing
;
Hu, Qiaoyu
  |  
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2024/03/26
Localized delivery of nanomedicine and antibodies for combating COVID-19
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 5, 页码: 1828-1846
作者:
Tu, Bin
;
Gao, Yanrong
;
An, Xinran
;
Wang, Huiyuan
;
Huang, Yongzhuo
  |  
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2023/10/17
SARS-CoV-2
COVID-19
Nanomedicine
Orally-inhaled delivery
Intranasal delivery
Antibody
Discovery of Polyphenolic Natural Products as SARS-CoV-2 Mpro Inhibitors for COVID-19
期刊论文
OAI收割
PHARMACEUTICALS, 2023, 卷号: 16, 期号: 2, 页码: 190
作者:
Kruger, Nadine
;
Kronenberger, Thales
;
Xie, Hang
;
Rocha, Cheila
;
Pohlmann, Stefan
  |  
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2024/03/27
antivirals
coronavirus
COVID-19
covalent drugs
dynamic light scattering
inhibitors
main protease
natural products